CTOs on the Move

Caduceus Marketing Research

www.cmr-usa.com

 
Caduceus Marketing Research is a Mount Arlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cmr-usa.com
  • 111 Howard Blvd Ste
    Mount Arlington, NJ USA 07856
  • Phone: 973.770.9752

Executives

Name Title Contact Details

Similar Companies

WellDoc

WellDoc is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rapid Healthcare

Rapid Healthcare Inc is proud to offer the best in clinical mobility solutions. Our goal is simple: work with an existing hospital infrastructure, understand their workflow, and supercharge it with the power and convenience of clinical mobility. By empowering clinical mobile solutions, every aspect of the healthcare industry experiences greater efficiency at a lower cost. Our solutions and creativity will revolutionize healthcare from admissions to discharge.

Addiction Recovery Resources (ARR)

Addiction Recovery Resources (ARR) is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

White Horse Village

White Horse Village Inc. is a non-profit, full service, lifecare community for people 62 and over, White Horse Village attracts those who want to design their own retirement lifestyle. The on-site Healthcare Center assures that our residents are provided with any necessary healthcare — be it temporary or permanent, personal care or skilled nursing care.

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.